Particle.news
Download on the App Store

Dave Coulier Reveals Early-Stage Tongue Cancer, Starts 35-Session Radiation

Routine follow-up scans caught the tumor early, which doctors say carries a strong likelihood of cure.

Overview

  • Coulier disclosed a p16-positive squamous cell carcinoma at the tongue/oropharynx after an October PET scan flagged an abnormality and biopsies confirmed the diagnosis.
  • He has begun a course of 35 radiation treatments scheduled on weekdays through the end of the year.
  • Physicians estimate roughly a 90% chance of cure for this early-stage, HPV-associated cancer type.
  • Doctors say the new tumor is medically distinct from his stage-3 Non-Hodgkin lymphoma treated with chemotherapy earlier this year.
  • Coulier reports side effects including nausea and difficulty swallowing and speaking, and he urges regular screenings after surveillance helped detect the tumor without symptoms.